Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 18 Sep 2006):

Attentional performance of (C57BL/6Jx129Sv)F2 mice in the five-choice serial reaction time task.

Full Abstract

Impaired attention is evident in several neurological and psychiatric disorders. In the present study, attentional capabilities were measured in the operant five-choice serial reaction time task (5-CSRTT) in male (C57BL/6Jx129Sv)F2 hybrid (B6129F2) mice. Main aims were to validate and standardize the test in these mice:
to setup procedures, measure potential beneficial effects of sub-chronic nicotine in degraded versions of the 5-CSRTT (by decreasing stimulus duration, inducing white noise and making the stimuli unpredictable) and study disruptive effects of additional administration of the muscarinic antagonist scopolamine. During the baseline pre-nicotine sessions, the B6129F2 mice attained a very good performance in the test (95% accuracy). As stimulus duration was reduced from 2 s to 1 s, response accuracy of the mice decreased. Mice treated with nicotine (0.16 mg/kg) attained significantly higher response accuracy and had a lower percentage of incorrect responses in comparison with the solvent-treated animals. No further beneficial effects of nicotine were found. Reduced response accuracy was also obtained when stimulus duration was reduced from 1 s to 0.5 s and when a variable intertrial interval was introduced. Noise interpolation between trials did not impair performance. Finally, scopolamine (0.16 mg/kg) disrupted attentional functioning. Although most studies have been performed in rats, these results add to the existing evidence that the 5-CSRTT can also be used to assess attentional performance in mice. This offers the opportunity to test transgenic and knockout mice with similar background as the B6129F2 as animal models of psychiatric and neurological diseases.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: de Bruin, N M W J (NM); Fransen, F (F); Duytschaever, H (H); Grantham, C (C); Megens, A A H P (AA);

Affiliation: Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), CNS Discovery Research, Belgium. natasja.debruin(-atsign-)solvay.com

Journal and publication information

Publication Type: Journal Article

Journal: Physiology & behavior (Physiol Behav), published in United States. (Language: eng)

Reference: 2006-Dec; vol 89 (issue 5) : pp 692-703

Dates: Created 2006/11/24; Completed 2007/01/26;

PMID: 16987534, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Muscarinic Antagonists (0) ; Nicotinic Agonists (0) ; Scopolamine (51-34-3) ; Nicotine (54-11-5)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

9/29/1994
2/10/2008
Higher Relevance Score (16)
Lower Relevance Score (10)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index